BackApyx Medical Overview

Apyx Medical Current Cash

Track Apyx Medical's current cash ($31M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$31.14M
↑ 0.41% YoYΔ $126000.00 vs prior year quarter

Peer average

Loading

Apyx Medical Current Cash History

Loading

Apyx Medical vs. peers: Current Cash Comparison

Loading

Apyx Medical Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Apyx Medical (APYX) FAQ

Apyx Medical (APYX) currently reports a current cash of $31M as of March 2026. That compares with $31M in the prior-year period — up 0.4% year over year. Use the charts on this page to explore Apyx Medical's current cash history and peer comparisons.

Apyx Medical's current cash increased from $31M to $31M — a 0.4% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Apyx Medical reported $31M in current cash as of March 2026. That compares with $31M in the prior-year period — up 0.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $31M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Apyx Medical, and consider following APYX for alerts when major investors trade the stock.

Apyx Medical is classified in the Healthcare sector. On current cash, it currently shows $31M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing APYX with unrelated industries.